ヘリオスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2019/07/03 | 1,761 | 1,770 | 1,726 | 1,750 | -7 | -0.4% | 96,300 |
2019/07/02 | 1,794 | 1,805 | 1,750 | 1,757 | -37 | -2.1% | 139,700 |
2019/07/01 | 1,800 | 1,829 | 1,784 | 1,794 | ±0 | ±0% | 97,600 |
2019/06/28 | 1,802 | 1,808 | 1,775 | 1,794 | -44 | -2.4% | 143,700 |
2019/06/27 | 1,828 | 1,843 | 1,785 | 1,838 | -8 | -0.4% | 199,800 |
2019/06/26 | 1,845 | 1,875 | 1,825 | 1,846 | -6 | -0.3% | 74,800 |
2019/06/25 | 1,832 | 1,862 | 1,808 | 1,852 | +41 | +2.3% | 87,500 |
2019/06/24 | 1,811 | 1,825 | 1,790 | 1,811 | +1 | +0.1% | 93,000 |
2019/06/21 | 1,877 | 1,880 | 1,805 | 1,810 | -73 | -3.9% | 102,700 |
2019/06/20 | 1,857 | 1,920 | 1,847 | 1,883 | +28 | +1.5% | 158,900 |
2019/06/19 | 1,836 | 1,859 | 1,822 | 1,855 | +24 | +1.3% | 81,800 |
2019/06/18 | 1,854 | 1,879 | 1,831 | 1,831 | -14 | -0.8% | 45,000 |
2019/06/17 | 1,830 | 1,862 | 1,824 | 1,845 | -14 | -0.8% | 38,900 |
2019/06/14 | 1,834 | 1,916 | 1,821 | 1,859 | +54 | +3% | 173,700 |
2019/06/13 | 1,823 | 1,823 | 1,794 | 1,805 | -26 | -1.4% | 52,500 |
2019/06/12 | 1,859 | 1,884 | 1,824 | 1,831 | -46 | -2.5% | 58,400 |
2019/06/11 | 1,870 | 1,886 | 1,843 | 1,877 | -1 | -0.1% | 64,900 |
2019/06/10 | 1,871 | 1,910 | 1,866 | 1,878 | +19 | +1% | 104,000 |
2019/06/07 | 1,794 | 1,878 | 1,793 | 1,859 | +82 | +4.6% | 202,000 |
2019/06/06 | 1,858 | 1,860 | 1,776 | 1,777 | -83 | -4.5% | 92,600 |
2019/06/05 | 1,780 | 1,888 | 1,764 | 1,860 | +160 | +9.4% | 382,900 |
2019/06/04 | 1,759 | 1,759 | 1,680 | 1,700 | +21 | +1.3% | 113,200 |
2019/06/03 | 1,718 | 1,733 | 1,669 | 1,679 | -79 | -4.5% | 86,600 |
2019/05/31 | 1,788 | 1,800 | 1,712 | 1,758 | -35 | -2% | 206,400 |
2019/05/30 | 1,800 | 1,810 | 1,767 | 1,793 | -22 | -1.2% | 114,600 |
2019/05/29 | 1,808 | 1,895 | 1,798 | 1,815 | -3 | -0.2% | 266,900 |
2019/05/28 | 1,716 | 1,832 | 1,714 | 1,818 | +104 | +6.1% | 280,200 |
2019/05/27 | 1,690 | 1,754 | 1,680 | 1,714 | +29 | +1.7% | 158,600 |
2019/05/24 | 1,650 | 1,694 | 1,650 | 1,685 | +15 | +0.9% | 91,400 |
2019/05/23 | 1,700 | 1,700 | 1,650 | 1,670 | -23 | -1.4% | 81,100 |
2019/05/22 | 1,738 | 1,745 | 1,674 | 1,693 | -26 | -1.5% | 170,800 |
2019/05/21 | 1,646 | 1,739 | 1,622 | 1,719 | +50 | +3% | 283,400 |
2019/05/20 | 1,680 | 1,680 | 1,640 | 1,669 | +4 | +0.2% | 94,800 |
2019/05/17 | 1,699 | 1,707 | 1,650 | 1,665 | +6 | +0.4% | 121,200 |
2019/05/16 | 1,681 | 1,688 | 1,636 | 1,659 | +47 | +2.9% | 182,400 |
2019/05/15 | 1,664 | 1,669 | 1,587 | 1,612 | -36 | -2.2% | 254,600 |
2019/05/14 | 1,650 | 1,665 | 1,632 | 1,648 | -33 | -2% | 219,700 |
2019/05/13 | 1,711 | 1,720 | 1,666 | 1,681 | -35 | -2% | 110,700 |
2019/05/10 | 1,759 | 1,785 | 1,700 | 1,716 | -28 | -1.6% | 192,900 |
2019/05/09 | 1,785 | 1,799 | 1,738 | 1,744 | -36 | -2% | 109,800 |
2019/05/08 | 1,822 | 1,843 | 1,769 | 1,780 | -96 | -5.1% | 227,600 |
2019/05/07 | 1,834 | 1,892 | 1,763 | 1,876 | +14 | +0.8% | 269,900 |
2019/04/26 | 1,901 | 1,904 | 1,812 | 1,862 | -70 | -3.6% | 285,100 |
2019/04/25 | 1,937 | 1,961 | 1,901 | 1,932 | -9 | -0.5% | 270,100 |
2019/04/24 | 2,000 | 2,005 | 1,936 | 1,941 | -54 | -2.7% | 151,400 |
2019/04/23 | 2,018 | 2,040 | 1,932 | 1,995 | -8 | -0.4% | 297,200 |
2019/04/22 | 1,900 | 2,045 | 1,864 | 2,003 | +73 | +3.8% | 545,700 |
2019/04/19 | 2,020 | 2,023 | 1,888 | 1,930 | ±0 | ±0% | 547,700 |
2019/04/18 | 1,845 | 2,114 | 1,827 | 1,930 | +108 | +5.9% | 1,728,900 |
2019/04/17 | 1,782 | 1,845 | 1,776 | 1,822 | +46 | +2.6% | 225,500 |
1501~
1550
件表示中 / 2491件
類似銘柄と比較する
現在ご覧いただいている「ヘリオス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ヘリオス | 57,300円 | +150.0% | - | 0.00% | - | 52.71倍 |
|
iPS細胞、体性幹細胞を活用する再生医薬品バイオベンチャー。住友ファーマと共同開発も |
JCRファーマ | 62,900円 | +14.3% | - | 3.18% | 25.57倍 | 1.63倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
あすかHD | 254,000円 | +16.9% | +33.2% | 2.17% | 13.87倍 | 1.10倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。21年春にあすか製薬が持株会社化 |
クオリプス | 739,000円 | +237.1% | - | 0.00% | - | 11.01倍 |
|
大阪大学発ベンチャー。iPS細胞由来のシートによる世界初の重症心不全治療法開発に注力 |
タウンズ | 58,300円 | +11.5% | -0.9% | 4.80% | 6.98倍 | 3.45倍 |
|
院内で行う迅速抗原検査の体外診断薬専業大手。新型コロナ、インフルなど呼吸器感染症首位 |
市場注目の銘柄
チャート関連のコラム